Loading...
XNAS
OPCH
Market cap3.55bUSD
Aug 21, Last price  
23.70USD
1D
0.89%
1Q
13.23%
Jan 2017
469.71%
Name

Option Care Health Inc

Chart & performance

D1W1MN
XNAS:OPCH chart
P/E
17.10
P/S
0.63
EPS
1.39
Div yield, %
—
Shrs. gr., 5y
-2.03%
Rev. gr., 5y
13.25%
Revenues
5.65b
+13.03%
1,151,940,0001,197,732,0001,401,911,0001,329,525,000430,707,000554,506,000593,447,000696,473,000922,654,000982,223,000935,589,000817,190,0001,939,791,0002,310,417,0003,032,610,0003,438,640,0003,944,735,0004,302,324,0004,998,202,0005,649,519,000
Net income
208m
-2.00%
-38,289,0003,317,000-74,032,00054,099,000-69,142,0007,872,00064,707,000-69,654,000-147,468,000-300,128,000-42,765,000-64,196,000-6,115,000-75,920,000-8,076,000139,898,000150,556,000267,090,000211,823,000207,585,000
CFO
258m
-20.08%
-29,862,00024,187,000-8,746,00022,745,000-21,419,00026,969,00026,884,000-54,579,000-31,416,000-64,742,000-35,203,000-1,052,000-20,104,00039,467,000127,392,000208,569,000267,547,000371,295,000323,392,000258,447,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
URL
https://optioncarehealth.com/
IPO date
Aug 15, 1996
Employees
5,597
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT